Healthcare provider profile · identity verified

Archana Anand

Internal Medicine · ERIE, PA · NPI 1215231998

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	345	99
Pantoprazole Sodium	Pantoprazole Sodium	291	77
Amlodipine Besylate	Amlodipine Besylate	263	78
Rosuvastatin Calcium	Rosuvastatin Calcium	219	70
Gabapentin	Gabapentin	215	71
Metoprolol Succinate	Metoprolol Succinate	200	54
Levothyroxine Sodium	Levothyroxine Sodium	196	42
Losartan Potassium	Losartan Potassium	185	54
Lisinopril	Lisinopril	183	56
Omeprazole	Omeprazole	183	54
Fluticasone Propionate	Fluticasone Propionate	167	58
Metformin Hcl	Metformin Hcl	144	44
Albuterol Sulfate Hfa	Albuterol Sulfate	142	59
Tramadol Hcl	Tramadol Hcl	127	25
Trulicity	Dulaglutide	114	18
Topiramate	Topiramate	111	29
Famotidine	Famotidine	109	32
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	105	26
Metformin Hcl Er	Metformin Hcl	102	40
Tamsulosin Hcl	Tamsulosin Hcl	95	23
Metoprolol Tartrate	Metoprolol Tartrate	92	22
Duloxetine Hcl	Duloxetine Hcl	90	24
Pregabalin	Pregabalin	84	14
Trazodone Hcl	Trazodone Hcl	80	25
Sertraline Hcl	Sertraline Hcl	78	19
Hydrochlorothiazide	Hydrochlorothiazide	77	21
Potassium Chloride	Potassium Chloride	75	22
Ozempic	Semaglutide	72	15
Montelukast Sodium	Montelukast Sodium	71	20
Simvastatin	Simvastatin	70	19
Ezetimibe	Ezetimibe	69	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	64	21
Furosemide	Furosemide	62	18
Tizanidine Hcl	Tizanidine Hcl	61	suppressed
Pravastatin Sodium	Pravastatin Sodium	60	17
Clonazepam	Clonazepam	58	suppressed
Alprazolam	Alprazolam	56	18
Jardiance	Empagliflozin	55	21
Lorazepam	Lorazepam	55	17
Clopidogrel	Clopidogrel Bisulfate	52	16
Baclofen	Baclofen	50	suppressed
Atenolol	Atenolol	49	16
Buspirone Hcl	Buspirone Hcl	47	15
Fluoxetine Hcl	Fluoxetine Hcl	47	11
Fenofibrate	Fenofibrate Nanocrystallized	45	suppressed
Bupropion Xl	Bupropion Hcl	44	17
Citalopram Hbr	Citalopram Hydrobromide	44	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	44	25
Breo Ellipta	Fluticasone/Vilanterol	43	11
Paroxetine Hcl	Paroxetine Hcl	43	11
Ventolin Hfa	Albuterol Sulfate	43	14
Zolpidem Tartrate	Zolpidem Tartrate	42	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	41	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	11
Mometasone Furoate	Mometasone Furoate	40	18
Xarelto	Rivaroxaban	40	suppressed
Allopurinol	Allopurinol	37	13
Carvedilol	Carvedilol	36	11
Eliquis	Apixaban	35	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	35	14
Humalog Kwikpen U-100	Insulin Lispro	35	suppressed
Bumetanide	Bumetanide	34	suppressed
Azelastine Hcl	Azelastine Hcl	33	suppressed
Meclizine Hcl	Meclizine Hcl	33	11
Alendronate Sodium	Alendronate Sodium	32	11
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Synthroid	Levothyroxine Sodium	31	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	30	24
Ketoconazole	Ketoconazole	28	19
Methylprednisolone	Methylprednisolone	28	26
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	26
Diclofenac Sodium	Diclofenac Sodium	27	16
Finasteride	Finasteride	27	suppressed
Ondansetron Odt	Ondansetron	27	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	26	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	26	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Lidocaine	Lidocaine	25	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Celecoxib	Celecoxib	24	suppressed
Ibandronate Sodium	Ibandronate Sodium	24	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	24	suppressed
Mounjaro	Tirzepatide	24	suppressed
Sucralfate	Sucralfate	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	12
Morphine Sulfate Er	Morphine Sulfate	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Wegovy	Semaglutide	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	11
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	12
Spiriva Handihaler	Tiotropium Bromide	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Nyamyc	Nystatin	17	suppressed
Azithromycin	Azithromycin	16	16
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	16	14
Droplet Pen Needle	Pen Needle, Diabetic	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Meloxicam	Meloxicam	16	suppressed
Temazepam	Temazepam	16	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Fluconazole	Fluconazole	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Prednisone	Prednisone	14	12
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Diazepam	Diazepam	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Methylphenidate Er	Methylphenidate Hcl	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Nitroglycerin	Nitroglycerin	12	12
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Valsartan	Valsartan	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Colchicine	Colchicine	11	suppressed
Desonide	Desonide	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Nystatin	Nystatin	11	suppressed
Olanzapine	Olanzapine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error